Answers are grounded in this paper and cite their sources.
Background This study aims to assess the burden and economic impact of disease associated with plastic and reconstructive surgery in the United Kingdom (UK) as it has remained unclear to inform policy and research funding decisions. Method Data on the burden of disease were extracted from the Global Burden of Disease 2019 results tool for all available and relevant plastic surgery diseases. The economic burden of disease in UK pounds was calculated based on prior studies. A VSLY of £60,000 per person in the UK was sourced from ‘The Green Book’ published by HM Treasury and inflated using the UK Health Consumer Price Index (CPI). Data are presented as rate or counts with the associated uncertainty interval. Result In 2019, the estimated age-standardized incident rates (ASIRs), age-standardized death rates (ASDRs), and age-standardized DALYs (ASDALYs) of plastic surgery related conditions were 361.47 per 100,000, 19.5 per 100,000 and 551.0 per 100,000 respectively. Burn emerged as the leading contributor to the overall disease burden, accounting for 32%, followed by decubitus ulcer (21%) for, breast cancer (17%). The economic burden of plastic surgery-related diseases in the UK amounted to £34.3 billion in 2019, exhibiting a steady increase from £19.6 billion in 2010. Conclusions Plastic and reconstructive surgery-related diseases, primarily breast cancer, thermal burns, and malignant melanoma, impose a substantial burden on the UK healthcare system. These findings hold significant implications for national healthcare policy, funding allocation, and research prioritisation.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: